MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
2.430
-0.010
-0.41%
Opening 15:13 12/04 EST
OPEN
2.450
PREV CLOSE
2.440
HIGH
2.520
LOW
2.360
VOLUME
35.34K
TURNOVER
--
52 WEEK HIGH
6.46
52 WEEK LOW
2.050
MARKET CAP
7.89M
P/E (TTM)
-1.1000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EDSA last week (1125-1129)?
Weekly Report · 2d ago
Weekly Report: what happened at EDSA last week (1118-1122)?
Weekly Report · 11/25 10:50
Weekly Report: what happened at EDSA last week (1111-1115)?
Weekly Report · 11/18 10:47
Weekly Report: what happened at EDSA last week (1104-1108)?
Weekly Report · 11/11 10:58
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/04 13:57
Weekly Report: what happened at EDSA last week (1028-1101)?
Weekly Report · 11/04 10:56
Edesa Biotech Gains CEO’s Strategic Investment Boost
TipRanks · 10/31 12:50
Edesa Biotech founder Par Nijhawan to invest up to $5M in company
TipRanks · 10/31 12:33
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. The Company's most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. It is evaluating EB05 in a Phase III study as a potential treatment for acute respiratory distress syndrome, a life-threatening form of respiratory failure. EB05 has also been included in a United States government funded platform study of host directed therapeutics. It has received Canadian regulatory approval to conduct a Phase II trial its EB06 (anti-CXCL10) monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. It is developing an sPLA2 inhibitor, EB01 (1.0% daniluromer cream), as a topical treatment for chronic Allergic Contact Dermatitis, a common occupational skin condition.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.